Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 03:20PM GMT
Release Date Price: $33.37 (-1.04%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

I'm Tejas Savant from the life science tools and diagnostics team at Morgan Stanley. It's my pleasure today to host Guardant Health. And from the company, we have Helmy, Amirali and Mike. So thanks, gents, for doing this. Let's kick it off. So maybe, Helmy, just to set the stage, could you share your vision for the company when you started it, where are you in that journey today? One of the things that sort of jumped out to me last Friday at the Analyst Day was how far you've come as a company since we first met sort of all those years ago? What's gone well? And where has progress been slower than you had hoped for?

Questions & Answers

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, Co-CEO & Chairman

Yes. It's actually very interesting. When we started the company, we had almost exactly the same vision that we've really turned into reality today, 11 years later this idea of really following the continuum of care towards a simple blood test for early detection of cancer,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot